CA2505169A1 - Collagen-based materials and methods for treating synovial joints - Google Patents
Collagen-based materials and methods for treating synovial joints Download PDFInfo
- Publication number
- CA2505169A1 CA2505169A1 CA002505169A CA2505169A CA2505169A1 CA 2505169 A1 CA2505169 A1 CA 2505169A1 CA 002505169 A CA002505169 A CA 002505169A CA 2505169 A CA2505169 A CA 2505169A CA 2505169 A1 CA2505169 A1 CA 2505169A1
- Authority
- CA
- Canada
- Prior art keywords
- collagen
- based material
- joint
- synovial joint
- synovial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/70—Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
- A61B17/7094—Solid vertebral fillers; devices for inserting such fillers
- A61B17/7095—Solid vertebral fillers; devices for inserting such fillers the filler comprising unlinked macroscopic particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4601—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
- A61L27/3856—Intervertebral discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/562—Implants for placement in joint gaps without restricting joint motion, e.g. to reduce arthritic pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
- A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
- A61B17/70—Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
- A61B17/7062—Devices acting on, attached to, or simulating the effect of, vertebral processes, vertebral facets or ribs ; Tools for such devices
- A61B17/7064—Devices acting on, attached to, or simulating the effect of, vertebral facets; Tools therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B2017/564—Methods for bone or joint treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30075—Properties of materials and coating materials swellable, e.g. when wetted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/3008—Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30224—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30581—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid
- A61F2002/30588—Special structural features of bone or joint prostheses not otherwise provided for having a pocket filled with fluid, e.g. liquid filled with solid particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
- A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/444—Intervertebral or spinal discs, e.g. resilient for replacing the nucleus pulposus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/445—Intervertebral disc tissue harvest sites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
- A61F2/4603—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2002/4625—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof with relative movement between parts of the instrument during use
- A61F2002/4627—Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof with relative movement between parts of the instrument during use with linear motion along or rotating motion about the instrument axis or the implantation direction, e.g. telescopic, along a guiding rod, screwing inside the instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0061—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
Abstract
A method of treating a synovial joint by injecting particles of collagen-bas ed material into the joint. The particles may be dehydrated before implantation , and rehydrated after implantation, or they may be implanted in a "wet" state - such as a slurry or gel. Radiocontrast materials may be included to enhance imaging of the injected material. Other additives may include analgesics, antibiotics, proteoglycans, growth factors, and/or other cells effective to promote healing and/or proper joint function.
Description
COLLAGEN-BASED MATERTALS AND METHODS
FOR TREATING SYNOVIAL JOINTS
FIELD OF THE INVENTION
The present invention relates generally to materials and methods for treating synovial joints, and more particularly to materials and methods for augmenting synovial joints with collagen-based materials.
BACKGROUND OF THE INVENTION
Synovial joints are the most common joints of the mammalian appendicular skeleton, representing highly evolved, movable joints. A typical synovial joint comprises two bone ends covered by layer of articular cartilage. The cartilage is smooth and resilient, and facilitates low-friction movement of the bones in the joint.
The bone ends and associated cartilage are surrounded by a joint capsule - a "sack" of membrane that produces synovial fluid. The capsule and fluid protect and support the cartilage and connective tissue, carrying nutrients to the articular cartilage and removing the metabolic wastes.
The articular cartilage is a thin (2-3mm) layer of hyaline cartilage on the epiphysis of the bone. It lacks a perichondrium, and thus has a limited capacity for repair when damaged. Additionally, the natural aging process can cause the articular cartilage to degenerate somewhat, reducing its capacity to protect and cushion the bone ends.
Zygapophysial joints, better known as facet joints, are the mechanism by which each vertebra of the spine connects to the vertebra above and/or below it.
Each joint comprises two facet bones - an inferior facet and a superior facet - with the inferior facet of one vertebra connecting to the superior facet of an adjacent vertebra. The joints facilitate movement of the vertebra relative to each other, and allow the spine to bend and twist.
As in all synovial joints, where the facets contact each other there is a lining of cartilage lubricated by a thin layer of synovial fluid. The cartilage and synovial fluid decrease friction at the joint, extending joint life and preventing inflammation and associated pain.
As the natural aging process progresses, the cartilage covering the joint may deteriorate and start to fray. The fraying process may cause pieces of cartilage to break free, and the previously smooth surfaces may become rough. The facet bones then begin to rub together, creating friction which leads to fuxther detexioxation of the joint.
Moreover, the nerves associated with the joint become irritated and inflamed, causing severe pain and restricting movement of the spine.
Techniques for addressing degeneration of synovial joints in general, and facet IO joints in particular, joint have heretofore relied primarily on injections to block pain and reduce inflammation. This treatment is only temporary though, and rarely leads to any significant improvement of the underlying condition.
A need therefore exists for materials and methods effective for treating degenerating synovial joints, and particularly for materials and methods effective for supplementing or replacing the cartilage that lubricates and protects the joint. The present invention addresses that need.
SUMMARY OF THE INVENTION
Briefly describing one aspect of the present invention, thexe is pxovided a method for treating synovial joints by injecting a collagen-based material into the joint. The material may be injected in a dehydrated form, and rehydrated after implantation, or it may be injected in a hydrated form, such as a slurry or gel. The material may be fresh or frozen. Cross-linking agents such as glutaraldehyde may be included in the injected material to promote collagen crosslinking. In addition, radio-contrast materials may be included to enhance imaging of the injected material. Similarly, performance-enhancing additives such as analgesics and/or antibiotics may be included to provide additional therapeutic benefits.
Objects and advantages of the claimed invention will be apparent from the following description.
FOR TREATING SYNOVIAL JOINTS
FIELD OF THE INVENTION
The present invention relates generally to materials and methods for treating synovial joints, and more particularly to materials and methods for augmenting synovial joints with collagen-based materials.
BACKGROUND OF THE INVENTION
Synovial joints are the most common joints of the mammalian appendicular skeleton, representing highly evolved, movable joints. A typical synovial joint comprises two bone ends covered by layer of articular cartilage. The cartilage is smooth and resilient, and facilitates low-friction movement of the bones in the joint.
The bone ends and associated cartilage are surrounded by a joint capsule - a "sack" of membrane that produces synovial fluid. The capsule and fluid protect and support the cartilage and connective tissue, carrying nutrients to the articular cartilage and removing the metabolic wastes.
The articular cartilage is a thin (2-3mm) layer of hyaline cartilage on the epiphysis of the bone. It lacks a perichondrium, and thus has a limited capacity for repair when damaged. Additionally, the natural aging process can cause the articular cartilage to degenerate somewhat, reducing its capacity to protect and cushion the bone ends.
Zygapophysial joints, better known as facet joints, are the mechanism by which each vertebra of the spine connects to the vertebra above and/or below it.
Each joint comprises two facet bones - an inferior facet and a superior facet - with the inferior facet of one vertebra connecting to the superior facet of an adjacent vertebra. The joints facilitate movement of the vertebra relative to each other, and allow the spine to bend and twist.
As in all synovial joints, where the facets contact each other there is a lining of cartilage lubricated by a thin layer of synovial fluid. The cartilage and synovial fluid decrease friction at the joint, extending joint life and preventing inflammation and associated pain.
As the natural aging process progresses, the cartilage covering the joint may deteriorate and start to fray. The fraying process may cause pieces of cartilage to break free, and the previously smooth surfaces may become rough. The facet bones then begin to rub together, creating friction which leads to fuxther detexioxation of the joint.
Moreover, the nerves associated with the joint become irritated and inflamed, causing severe pain and restricting movement of the spine.
Techniques for addressing degeneration of synovial joints in general, and facet IO joints in particular, joint have heretofore relied primarily on injections to block pain and reduce inflammation. This treatment is only temporary though, and rarely leads to any significant improvement of the underlying condition.
A need therefore exists for materials and methods effective for treating degenerating synovial joints, and particularly for materials and methods effective for supplementing or replacing the cartilage that lubricates and protects the joint. The present invention addresses that need.
SUMMARY OF THE INVENTION
Briefly describing one aspect of the present invention, thexe is pxovided a method for treating synovial joints by injecting a collagen-based material into the joint. The material may be injected in a dehydrated form, and rehydrated after implantation, or it may be injected in a hydrated form, such as a slurry or gel. The material may be fresh or frozen. Cross-linking agents such as glutaraldehyde may be included in the injected material to promote collagen crosslinking. In addition, radio-contrast materials may be included to enhance imaging of the injected material. Similarly, performance-enhancing additives such as analgesics and/or antibiotics may be included to provide additional therapeutic benefits.
Objects and advantages of the claimed invention will be apparent from the following description.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGS. lA-1D show a procedure for injecting a collagen-based material into a facet joint, according to one preferred embodiment of the present invention.
FIGS. 2A-2F show a procedure for injecting a collagen-based material into a facet joint, according to another preferred embodiment of the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to certain preferred embodiments and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the preferred embodiments being contemplated as would normally occur to one skilled in the art to which the invention relates.
As indicated above, one aspect of the present invention relates to materials and methods for using collagen-based material to treat a degenerating synovial joint. In the most preferred embodiments the collagen-based material is injected into the joint capsule.
In some preferred embodiments the inventive method includes surgically adding to a synovial joint a composition comprising particulate collagen-based material.
In other embodiments the inventive method includes surgically adding to a synovial joint a composition consisting essentially of particulate collagen-based material.
The collagen-based material may be derived from natural, collagen-rich tissue, such as intervertebral disc, fascia, ligament, tendon, demineralized bone matrix, etc. The material may be autogenic, allogenic, or xenogenic, or it may be of human-recombinant origin. In alternative embodiments the collagen-based material may be a synthetic, collagen-based material. Examples of preferred collagen-rich tissues include disc annulus, fascia lata, planar fascia, anterior or posterior cruciate ligaments, patella tendon, hamstring tendons, quadriceps tendons, Achilles tendons, skins, and other connective tissues.
FIGS. lA-1D show a procedure for injecting a collagen-based material into a facet joint, according to one preferred embodiment of the present invention.
FIGS. 2A-2F show a procedure for injecting a collagen-based material into a facet joint, according to another preferred embodiment of the present invention.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to certain preferred embodiments and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the preferred embodiments being contemplated as would normally occur to one skilled in the art to which the invention relates.
As indicated above, one aspect of the present invention relates to materials and methods for using collagen-based material to treat a degenerating synovial joint. In the most preferred embodiments the collagen-based material is injected into the joint capsule.
In some preferred embodiments the inventive method includes surgically adding to a synovial joint a composition comprising particulate collagen-based material.
In other embodiments the inventive method includes surgically adding to a synovial joint a composition consisting essentially of particulate collagen-based material.
The collagen-based material may be derived from natural, collagen-rich tissue, such as intervertebral disc, fascia, ligament, tendon, demineralized bone matrix, etc. The material may be autogenic, allogenic, or xenogenic, or it may be of human-recombinant origin. In alternative embodiments the collagen-based material may be a synthetic, collagen-based material. Examples of preferred collagen-rich tissues include disc annulus, fascia lata, planar fascia, anterior or posterior cruciate ligaments, patella tendon, hamstring tendons, quadriceps tendons, Achilles tendons, skins, and other connective tissues.
The collagen-based material may be provided in any form appropriate for introduction into a synovial joint. For example, the material may be a solid, porous, woven, or non-woven material, and may be provided as particles, small pieces, gel, solution, suspension, paste, fibrous material, etc. The material may be used while it is still fresh and hydrated, or it may be used after having been processed, such as having been frozen and/or dehydrated.
In some embodiments the material is provided in a dehydrated state, and is "rehydrated" after injection in the joint. In other embodiments the material is implanted in a hydrated state. When the material is implanted in a hydrated state, it may be that way because it has never been dehydrated, or it may have been dehydrated arid reconstituted.
When reconstituted, the material may be reconstituted with saline or another aqueous medium, or it may be reconstituted with a non-aqueous medium such as ethylene glycol or another alcohol. Moreover, When provided in a "hydxated" state, the material may be provided as a gel, solution, suspension, dispersion, emulsion, paste, etc.
In the most preferred embodiments the material is a particulate and/or fibrous material suitable for injection through a hypodermic needle into a synovial joint.
In the most preferred embodiments the collagen material is provided as particles ranging between .OSmm and Smm in size. When materials such as fascia lata or disc annulus particles are used the particles preferably range in size from .lmm to Smm. When materials such as demineralized bone matrix or gelatin are used the particles preferably range in size from .OSmm to 3mm. When small plugs of material are used the plugs preferably range in size from .Smm to Smm. In some embodiments larger sized pieces, such as pieces up to 20mm in size, may be used.
The materials may be processed or fabricated using more than one type of tissue.
For example, mixtures of fascia lata and demineralized bone matrix may be preferred in appropriate cases, as may mixtures of DBM and annulus fibrosis material.
Cross-linking agents may be added to the formulation to promote cross-linking of the collagen material. For example, glutaraldehyde or other protein cross-linking agents may be included in the formulation. The cross-linking agents may promote covalent or non-covalent crosslinlcs between collagen molecules. Similarly, agents to inhibit protein denaturization may also be included. Crosslinking agents that would be appropriate for use in the claimed invention are known to persons skilled in the art, and may be selected without undue experimentation.
When the material is to be used as a slurry or gel, additives to promote slurry or gel formation may also be included. These additives may promote protein folding, water binding, protein-protein interactions, and water immobilization.
In addition, a radiographic contrast media, such as barium sulfate, or a radiocontrast dye, such as sodium diatrizoate (HYPAQUE~), may be included to aid the surgeon in tracking the movement and/or location of the injected material.
Radiocontrast materials appropriate for use in discography are known to persons skilled in the art, and may be selected for use in the present invention without undue experimentation.
Finally, other additives to provide benefits to the injected collagen-based material may also be included. Such additives include analgesics to reduce pain, antibiotics to minimize the potential for bacterial infection.
Polysaccharides such as proteoglycans and/or hyaluronic acid may also be included to attract and/or bind water to keep the synovial j oint hydrated.
Additionally, growth factors and/or other cells (e.g., intervertebral disc cells, stem cells, etc.) to promote healing, repair, regeneration and/or restoration of the joint, and/or to facilitate proper joint function, may also be included. Additives appropriate for use in the claimed invention are known to persons skilled in the art, and may be selected without undue experimentation.
In some embodiments the collagen material is dehydrated before injection into the joint, where it is rehydrated by absorbing fluid from the surrounding area. In other embodiments the collagen material is provided as a gel, slurry, or other hydrated formulation before implantation.
The collagen-based material is "surgically added" to the synovial joint. That is, the material is added by the intervention of medical personnel, as distinguished from being "added" by the body's natural growth or regeneration processes. The surgical procedure preferably includes injection through a hypodermic needle, although other surgical methods of introducing the collagen-based material into the joint may be used.
For example, the material may be introduced into a synovial joint by extrusion through a dilated opening, infusion through a catheter, insertion through an opening created by trauma or surgical incision, or by other means of invasive or minimally invasive deposition of the materials into the joint space.
Referring now to the drawings, FIGS. lA-1D show one method of injecting a collagen-based material into a joint. In FIG. lA, dehydrated particulate fascia Iata or annulus ribrosis material 11 is provided in a syringe 12 (in a sterile package). The material is rehydrated andlor dispersed in a suspension medium as shown in FIG. 1B, to provide a wet dispersion 13 of collagen-based material. A hypodermic needle 14 is attached to syringe 12, and the syringe is inserted into the joint capsule 16 (FIG. 1 C). The needle/syringe may be moved around within the joint capsule, sweeping from side to side and back and forth, to ensure uniform distribution of the collagen-based material 13 within the space, as shown in FIG. 1D. It is preferred, however, that the tip of the needle be maintained near the center of the joint capsule to ensure deposition of the material within the space, and to minimize potential leakage.
Alternatively, small diameter collagen plugs 21 may be inserted into the joint as shown in FIGS. 2A-2F. The collagen plugs 21 may be compressed before or by insertion into a small diameter tube 22, and are provided in a delivery cannula 23 (FIGS. 2A-2C).
The delivery cannula 23 is attached to a dilator 24.
The compressed plugs axe inserted into a joint 25 by penetrating the joint with a guide needle 27 (FIG. 2D). Dilator 24, preferably with delivery cannula 23 already attached, is inserted over guide needle 27 (FIG. 2E). The collagen plugs 21 are then ready for injection (or extrusion) into the joint. A plunger 28 may be used to push the plugs from the carmula. The plugs expand upon exiting the dilator, and may further expand as they rehydrate in the j oint.
Benerits and advantages arising from use of the materials and methods of the present invention include the following:
(1) the invention provides lubrication and/or cushioning to degenerated synovial joints, improving or restoring proper joint function;
(2) the rehydration provided by the invention is expected to slow the degenerative process;
(3) the invention relieves pain due to improved lubrication of the joint;
(4) the procedure is percutaneous or a minimally invasive outpatient procedure;
In some embodiments the material is provided in a dehydrated state, and is "rehydrated" after injection in the joint. In other embodiments the material is implanted in a hydrated state. When the material is implanted in a hydrated state, it may be that way because it has never been dehydrated, or it may have been dehydrated arid reconstituted.
When reconstituted, the material may be reconstituted with saline or another aqueous medium, or it may be reconstituted with a non-aqueous medium such as ethylene glycol or another alcohol. Moreover, When provided in a "hydxated" state, the material may be provided as a gel, solution, suspension, dispersion, emulsion, paste, etc.
In the most preferred embodiments the material is a particulate and/or fibrous material suitable for injection through a hypodermic needle into a synovial joint.
In the most preferred embodiments the collagen material is provided as particles ranging between .OSmm and Smm in size. When materials such as fascia lata or disc annulus particles are used the particles preferably range in size from .lmm to Smm. When materials such as demineralized bone matrix or gelatin are used the particles preferably range in size from .OSmm to 3mm. When small plugs of material are used the plugs preferably range in size from .Smm to Smm. In some embodiments larger sized pieces, such as pieces up to 20mm in size, may be used.
The materials may be processed or fabricated using more than one type of tissue.
For example, mixtures of fascia lata and demineralized bone matrix may be preferred in appropriate cases, as may mixtures of DBM and annulus fibrosis material.
Cross-linking agents may be added to the formulation to promote cross-linking of the collagen material. For example, glutaraldehyde or other protein cross-linking agents may be included in the formulation. The cross-linking agents may promote covalent or non-covalent crosslinlcs between collagen molecules. Similarly, agents to inhibit protein denaturization may also be included. Crosslinking agents that would be appropriate for use in the claimed invention are known to persons skilled in the art, and may be selected without undue experimentation.
When the material is to be used as a slurry or gel, additives to promote slurry or gel formation may also be included. These additives may promote protein folding, water binding, protein-protein interactions, and water immobilization.
In addition, a radiographic contrast media, such as barium sulfate, or a radiocontrast dye, such as sodium diatrizoate (HYPAQUE~), may be included to aid the surgeon in tracking the movement and/or location of the injected material.
Radiocontrast materials appropriate for use in discography are known to persons skilled in the art, and may be selected for use in the present invention without undue experimentation.
Finally, other additives to provide benefits to the injected collagen-based material may also be included. Such additives include analgesics to reduce pain, antibiotics to minimize the potential for bacterial infection.
Polysaccharides such as proteoglycans and/or hyaluronic acid may also be included to attract and/or bind water to keep the synovial j oint hydrated.
Additionally, growth factors and/or other cells (e.g., intervertebral disc cells, stem cells, etc.) to promote healing, repair, regeneration and/or restoration of the joint, and/or to facilitate proper joint function, may also be included. Additives appropriate for use in the claimed invention are known to persons skilled in the art, and may be selected without undue experimentation.
In some embodiments the collagen material is dehydrated before injection into the joint, where it is rehydrated by absorbing fluid from the surrounding area. In other embodiments the collagen material is provided as a gel, slurry, or other hydrated formulation before implantation.
The collagen-based material is "surgically added" to the synovial joint. That is, the material is added by the intervention of medical personnel, as distinguished from being "added" by the body's natural growth or regeneration processes. The surgical procedure preferably includes injection through a hypodermic needle, although other surgical methods of introducing the collagen-based material into the joint may be used.
For example, the material may be introduced into a synovial joint by extrusion through a dilated opening, infusion through a catheter, insertion through an opening created by trauma or surgical incision, or by other means of invasive or minimally invasive deposition of the materials into the joint space.
Referring now to the drawings, FIGS. lA-1D show one method of injecting a collagen-based material into a joint. In FIG. lA, dehydrated particulate fascia Iata or annulus ribrosis material 11 is provided in a syringe 12 (in a sterile package). The material is rehydrated andlor dispersed in a suspension medium as shown in FIG. 1B, to provide a wet dispersion 13 of collagen-based material. A hypodermic needle 14 is attached to syringe 12, and the syringe is inserted into the joint capsule 16 (FIG. 1 C). The needle/syringe may be moved around within the joint capsule, sweeping from side to side and back and forth, to ensure uniform distribution of the collagen-based material 13 within the space, as shown in FIG. 1D. It is preferred, however, that the tip of the needle be maintained near the center of the joint capsule to ensure deposition of the material within the space, and to minimize potential leakage.
Alternatively, small diameter collagen plugs 21 may be inserted into the joint as shown in FIGS. 2A-2F. The collagen plugs 21 may be compressed before or by insertion into a small diameter tube 22, and are provided in a delivery cannula 23 (FIGS. 2A-2C).
The delivery cannula 23 is attached to a dilator 24.
The compressed plugs axe inserted into a joint 25 by penetrating the joint with a guide needle 27 (FIG. 2D). Dilator 24, preferably with delivery cannula 23 already attached, is inserted over guide needle 27 (FIG. 2E). The collagen plugs 21 are then ready for injection (or extrusion) into the joint. A plunger 28 may be used to push the plugs from the carmula. The plugs expand upon exiting the dilator, and may further expand as they rehydrate in the j oint.
Benerits and advantages arising from use of the materials and methods of the present invention include the following:
(1) the invention provides lubrication and/or cushioning to degenerated synovial joints, improving or restoring proper joint function;
(2) the rehydration provided by the invention is expected to slow the degenerative process;
(3) the invention relieves pain due to improved lubrication of the joint;
(4) the procedure is percutaneous or a minimally invasive outpatient procedure;
(5) the risks are minimal, as similar techniques and materials are used in cosmetic procedures;
(6) the materials are biocompatible since natural or human-recombinant collagen-based materials are used;
In one preferred embodiment the materials and methods of the present invention may be used to treat synovial joints in the spine, particularly facet joints.
In other preferred embodiments hip, knee, ankle, finger, toe, elbow, shoulder, wrist, sacroiliac, temporomandibular, carpometacarpal, etc., joints may all be treated by injecting a collagen-source material into the joint space to supplernent/augment the cartilage that lubricates the joint.
Reference will now be made to specific examples using the processes described above. It is to be understood that the examples are provided to more completely describe preferred embodiments, and.that no limitation to the scope of the invention is intended IS thereby.
Example 1 A gel or suspension of hydrated particulate or fibrous (autologous or allogenic) fascia late in a biocompatible medium such as water, saline, or ethylene glycol is used to supplement the cartilage of a facet joint. The particle size can be in the range from 0.01 mm to 5 mm, preferably between 0.05 and 0.25 mm. The suspension is injected directly into the articular facet joint space through an intact joint capsule using a hypodermic needle. The suspension is contained within the joint capsule following injection. The medium subsequently diffuses out of the disc space and leaves the hydrated fascia late material behind. A single injection is effective for improving the facet joint structure, although additional injections may be necessary to achieve appropriate level of treatment.
Example 2 A gel or suspension of hydrated particulate or fibrous allogenic annulus fibrosis in a biocompatible medium such as water, saline or ethylene glycol is used to supplement the cartilage of a facet joint. The particle size can be in the range from 0.01 mm to 5 mm, preferably between 0.05 and 0.25 mm. The suspension is injected directly into the articular facet joint space through an intact joint capsule using a hypodermic needle. The suspension is contained within the joint capsule following injection. The medium subsequently diffuses out of the disc space and leaves the hydrated annulus fibrosis material behind. Single injection is desirable; however, additional injections may be necessary to achieve the appropriate level of treatment.
Example 3 Dehydrated annulus fibrosis material in granule, particulate or power form is used to supplement the cartilage of a facet joint. The particle size can range between 0.01 mm and 5 mm, preferably between 0.05 to 0.25 mm. The material is loaded in its dehydrated state into a specially designed syringe for delivery of particulate matter.
The material is extruded into the articular facet joint space through a small, dilated capsule opening. The material remains inside the articulating facet joint space after the needle is removed. It subsequently absorbs moisture or body fluids and swells up in vivo.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
In one preferred embodiment the materials and methods of the present invention may be used to treat synovial joints in the spine, particularly facet joints.
In other preferred embodiments hip, knee, ankle, finger, toe, elbow, shoulder, wrist, sacroiliac, temporomandibular, carpometacarpal, etc., joints may all be treated by injecting a collagen-source material into the joint space to supplernent/augment the cartilage that lubricates the joint.
Reference will now be made to specific examples using the processes described above. It is to be understood that the examples are provided to more completely describe preferred embodiments, and.that no limitation to the scope of the invention is intended IS thereby.
Example 1 A gel or suspension of hydrated particulate or fibrous (autologous or allogenic) fascia late in a biocompatible medium such as water, saline, or ethylene glycol is used to supplement the cartilage of a facet joint. The particle size can be in the range from 0.01 mm to 5 mm, preferably between 0.05 and 0.25 mm. The suspension is injected directly into the articular facet joint space through an intact joint capsule using a hypodermic needle. The suspension is contained within the joint capsule following injection. The medium subsequently diffuses out of the disc space and leaves the hydrated fascia late material behind. A single injection is effective for improving the facet joint structure, although additional injections may be necessary to achieve appropriate level of treatment.
Example 2 A gel or suspension of hydrated particulate or fibrous allogenic annulus fibrosis in a biocompatible medium such as water, saline or ethylene glycol is used to supplement the cartilage of a facet joint. The particle size can be in the range from 0.01 mm to 5 mm, preferably between 0.05 and 0.25 mm. The suspension is injected directly into the articular facet joint space through an intact joint capsule using a hypodermic needle. The suspension is contained within the joint capsule following injection. The medium subsequently diffuses out of the disc space and leaves the hydrated annulus fibrosis material behind. Single injection is desirable; however, additional injections may be necessary to achieve the appropriate level of treatment.
Example 3 Dehydrated annulus fibrosis material in granule, particulate or power form is used to supplement the cartilage of a facet joint. The particle size can range between 0.01 mm and 5 mm, preferably between 0.05 to 0.25 mm. The material is loaded in its dehydrated state into a specially designed syringe for delivery of particulate matter.
The material is extruded into the articular facet joint space through a small, dilated capsule opening. The material remains inside the articulating facet joint space after the needle is removed. It subsequently absorbs moisture or body fluids and swells up in vivo.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
Claims (40)
1. A method of treating a synovial joint, said method comprising surgically adding to a synovial joint a composition comprising particulate collagen-based material.
2. The method of claim 1 wherein said surgically adding step comprises injecting particulate collagen-based material into a synovial joint.
3. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.05mm to 5mm in size.
4. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.05mm to 3mm in size.
5. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.05mm to 1mm in size.
6. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.25mm to 1mm in size.
7. The method of claim 1 wherein said collagen-based material is injected in a dehydrated state.
8. The method of claim 1 wherein said collagen-based material is injected in a non-dehydrated state.
9. The method of claim 8 wherein said collagen-based material is injected as a gel.
10. The method of claim 8 wherein said collagen-based material is injected as a solution or suspension.
11. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes a cross-linking agent to promote crosslinking of collagen molecules.
12. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes a radiocontrast media.
13. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes an analgesic.
14. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes an antibiotic.
15. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes polysaccharides.
16. The method of claim 15 wherein said polysaccharide is a proteoglycan.
17. The method of claim 15 wherein said polysaccharide is hyaluronic acid.
18. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes growth factors.
19. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes one or more other types of cells effective to promote healing, repair, regeneration and/or restoration of a synovial joint, and/or to facilitate proper joint function.
20. A method according to any of claims 2 through 19 wherein said synovial joint is a facet joint.
21. A synovial joint with a collagen-based material injected in the joint capsule.
22. The synovial joint of claim 21 wherein said collagen-based material comprises particles of collagen-based material.
23 The synovial joint of claim 21 wherein said collagen-based material comprises particles ranging from 0.05mm to 5mm in size.
24. The synovial joint of claim 21 wherein said collagen-based material comprises particles ranging from 0.05mm to 3mm in size.
25. The synovial joint of claim 21 wherein said collagen-based material comprises particles ranging from 0.05mm to 1mm in size.
26. The synovial joint of claim 21 wherein said collagen-based material comprises particles ranging from 0.25mm to 1mm in size.
27. The synovial joint of claim 21 wherein said collagen-based material comprises collagen-based materials that have been reconstituted in the joint from dehydrated collagen-based materials.
28. The synovial joint of claim 21 wherein said collagen-based material comprises collagen-based materials that were injected into the joint in a non-dehydrated state.
29. The synovial joint of claim 21 wherein said collagen-based material comprises collagen-based materials that were injected into the joint as a gel.
30. The synovial joint of claim 21 wherein said collagen-based material comprises collagen-based materials that were injected into the joint as a solution or suspension.
31. The synovial joint of claim 21 wherein said collagen-based material additionally includes a cross-linking agent to promote crosslinking of collagen molecules.
32. The synovial joint of claim 21 wherein said collagen-based material additionally includes a radiocontrast media.
33. The synovial joint of claim 21 wherein said collagen-based material additionally includes an analgesic.
34. The synovial joint of claim 21 wherein said collagen-based material additionally includes an antibiotic.
35. The synovial joint of claim 21 wherein said collagen-based material additionally includes a polysaccharide.
36. The synovial joint of claim 35 wherein said polysaccharide is a proteoglycan.
37. The synovial joint of claim 35 wherein said polysaccharide is a hyaluronic acid.
38. The synovial joint of claim 21 wherein said collagen-based material additionally includes growth factors.
39. The synovial joint of claim 21 wherein said collagen-based material additionally includes one or more other types of cells effective to promote healing, repair, regeneration and/or restoration of a facet joint, and/or to facilitate proper joint function.
40. A synovial joint according to any of claims 21 through 39 wherein said synovial joint is a facet joint.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/245,955 US20040054414A1 (en) | 2002-09-18 | 2002-09-18 | Collagen-based materials and methods for augmenting intervertebral discs |
US42661302P | 2002-11-15 | 2002-11-15 | |
US60/426,613 | 2002-11-15 | ||
PCT/US2003/035959 WO2004045667A1 (en) | 2002-09-18 | 2003-11-10 | Collagen-based materials and methods for treating synovial joints |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2505169A1 true CA2505169A1 (en) | 2004-06-03 |
Family
ID=35107061
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002499111A Abandoned CA2499111A1 (en) | 2002-09-18 | 2003-09-16 | Collagen-based materials and methods for augmenting intervertebral discs |
CA002505169A Abandoned CA2505169A1 (en) | 2002-09-18 | 2003-11-10 | Collagen-based materials and methods for treating synovial joints |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002499111A Abandoned CA2499111A1 (en) | 2002-09-18 | 2003-09-16 | Collagen-based materials and methods for augmenting intervertebral discs |
Country Status (5)
Country | Link |
---|---|
US (3) | US20040054414A1 (en) |
EP (1) | EP1562652A1 (en) |
AU (2) | AU2003267269B2 (en) |
CA (2) | CA2499111A1 (en) |
WO (2) | WO2004026189A2 (en) |
Families Citing this family (156)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6726691B2 (en) * | 1998-08-14 | 2004-04-27 | Kyphon Inc. | Methods for treating fractured and/or diseased bone |
SK284040B6 (en) * | 1996-02-09 | 2004-08-03 | Abbott Laboratories (Bermuda) Ltd. | Human antibodies that bind human TNFalpha |
US7435260B2 (en) * | 1999-08-13 | 2008-10-14 | Ferree Bret A | Use of morphogenetic proteins to treat human disc disease |
US7951201B2 (en) | 1999-10-20 | 2011-05-31 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8128698B2 (en) | 1999-10-20 | 2012-03-06 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7615076B2 (en) * | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US7004970B2 (en) | 1999-10-20 | 2006-02-28 | Anulex Technologies, Inc. | Methods and devices for spinal disc annulus reconstruction and repair |
US7052516B2 (en) | 1999-10-20 | 2006-05-30 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and deformable spinal disc annulus stent |
US20030153976A1 (en) * | 1999-10-20 | 2003-08-14 | Cauthen Joseph C. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US6592625B2 (en) | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US8632590B2 (en) | 1999-10-20 | 2014-01-21 | Anulex Technologies, Inc. | Apparatus and methods for the treatment of the intervertebral disc |
US7935147B2 (en) | 1999-10-20 | 2011-05-03 | Anulex Technologies, Inc. | Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus |
US6805695B2 (en) | 2000-04-04 | 2004-10-19 | Spinalabs, Llc | Devices and methods for annular repair of intervertebral discs |
US6723335B1 (en) * | 2000-04-07 | 2004-04-20 | Jeffrey William Moehlenbruck | Methods and compositions for treating intervertebral disc degeneration |
JP2005511207A (en) * | 2001-12-10 | 2005-04-28 | コルバー・ライフサイエンス・リミテッド | Intervertebral disc treatment methods, devices, and preparations |
US6812211B2 (en) * | 2002-03-19 | 2004-11-02 | Michael Andrew Slivka | Method for nonsurgical treatment of the intervertebral disc and kit therefor |
US20050209699A1 (en) * | 2002-03-19 | 2005-09-22 | Slivka Michael A | Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor |
US7309359B2 (en) * | 2003-08-21 | 2007-12-18 | Warsaw Orthopedic, Inc. | Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs |
US20040054414A1 (en) * | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
KR101095771B1 (en) | 2002-09-18 | 2011-12-21 | 워쏘우 오르쏘페딕 인코포레이티드 | Natural tissue devices and methods of implantation |
US7744651B2 (en) * | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
JP2006505331A (en) * | 2002-11-05 | 2006-02-16 | スパインオロジー,インク. | Semi-artificial intervertebral disc replacement system |
JP2006515765A (en) | 2002-11-15 | 2006-06-08 | エスディージーアイ・ホールディングス・インコーポレーテッド | Collagen-based materials and methods for treating synovial joints |
US20040186471A1 (en) * | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
US20070003525A1 (en) * | 2003-01-31 | 2007-01-04 | Moehlenbruck Jeffrey W | Hydrogel compositions comprising nucleus pulposus tissue |
AU2004212942A1 (en) | 2003-02-14 | 2004-09-02 | Depuy Spine, Inc. | In-situ formed intervertebral fusion device |
US7648509B2 (en) | 2003-03-10 | 2010-01-19 | Ilion Medical Llc | Sacroiliac joint immobilization |
WO2004089240A2 (en) * | 2003-04-04 | 2004-10-21 | Theken Disc, Llc | Artificial disc prosthesis |
US20050131417A1 (en) * | 2003-08-22 | 2005-06-16 | Ahern James W. | Kit for treating bony defects |
US20050071012A1 (en) * | 2003-09-30 | 2005-03-31 | Hassan Serhan | Methods and devices to replace spinal disc nucleus pulposus |
ES2396689T3 (en) | 2003-12-11 | 2013-02-25 | Isto Technologies Inc. | Particle Cartilage System |
US7452351B2 (en) | 2004-04-16 | 2008-11-18 | Kyphon Sarl | Spinal diagnostic methods and apparatus |
US7824390B2 (en) | 2004-04-16 | 2010-11-02 | Kyphon SÀRL | Spinal diagnostic methods and apparatus |
WO2005113032A2 (en) | 2004-05-21 | 2005-12-01 | Synthes (U.S.A.) | Replacement of nucleus pulposus using a hydrogel |
US20050277921A1 (en) * | 2004-05-28 | 2005-12-15 | Sdgi Holdings, Inc. | Prosthetic joint and nucleus supplement |
CA2560222A1 (en) * | 2004-06-22 | 2006-01-05 | Jeffrey E. Yeung | Disc shunt for treating back pain |
US8512730B2 (en) | 2004-07-12 | 2013-08-20 | Isto Technologies, Inc. | Methods of tissue repair and compositions therefor |
CA2575383A1 (en) * | 2004-07-27 | 2006-02-09 | Synthes (U.S.A.) | Supplementation or replacement of a nucleus pulposus, of an intervertebral disc |
WO2006026731A1 (en) * | 2004-08-30 | 2006-03-09 | Spineovations, Inc. | Method of treating spinal internal disk derangement |
AU2005279960A1 (en) * | 2004-08-30 | 2006-03-09 | Neville Alleyne | Method of using an implant for treatment of ligaments and tendons |
US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
AU2005321543A1 (en) * | 2004-12-30 | 2006-07-06 | Cinvention Ag | Combination comprising an agent providing a signal, an implant material and a drug |
US7825083B2 (en) * | 2005-02-10 | 2010-11-02 | Spine Wave, Inc. | Synovial fluid barrier |
WO2006113586A2 (en) * | 2005-04-15 | 2006-10-26 | Musculoskeletal Transplant Foundation | Vertebral disc repair |
US20060241758A1 (en) * | 2005-04-20 | 2006-10-26 | Sdgi Holdings, Inc. | Facet spacers |
US8080061B2 (en) * | 2005-06-20 | 2011-12-20 | Synthes Usa, Llc | Apparatus and methods for treating bone |
JP4907908B2 (en) * | 2005-06-29 | 2012-04-04 | ルネサスエレクトロニクス株式会社 | Driving circuit and display device |
US8366773B2 (en) | 2005-08-16 | 2013-02-05 | Benvenue Medical, Inc. | Apparatus and method for treating bone |
US7670375B2 (en) | 2005-08-16 | 2010-03-02 | Benvenue Medical, Inc. | Methods for limiting the movement of material introduced between layers of spinal tissue |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
US8197545B2 (en) | 2005-10-27 | 2012-06-12 | Depuy Spine, Inc. | Nucleus augmentation delivery device and technique |
US8506633B2 (en) * | 2005-12-27 | 2013-08-13 | Warsaw Orthopedic, Inc. | Rehydration and restoration of intervertebral discs with polyelectrolytes |
US8801790B2 (en) * | 2005-12-27 | 2014-08-12 | Warsaw Orthopedic, Inc. | Intervertebral disc augmentation and rehydration with superabsorbent polymers |
US20070191861A1 (en) * | 2006-01-30 | 2007-08-16 | Sdgi Holdings, Inc. | Instruments and methods for implanting nucleus replacement material in an intervertebral disc nucleus space |
US20070227547A1 (en) * | 2006-02-14 | 2007-10-04 | Sdgi Holdings, Inc. | Treatment of the vertebral column |
US7520888B2 (en) * | 2006-02-14 | 2009-04-21 | Warsaw Orthopedic, Inc. | Treatment of the vertebral column |
US20070213718A1 (en) * | 2006-02-14 | 2007-09-13 | Sdgi Holdings, Inc. | Treatment of the vertebral column |
US20070213717A1 (en) * | 2006-02-14 | 2007-09-13 | Sdgi Holdings, Inc. | Biological fusion in the vertebral column |
US8016859B2 (en) | 2006-02-17 | 2011-09-13 | Medtronic, Inc. | Dynamic treatment system and method of use |
WO2008075206A2 (en) * | 2006-05-19 | 2008-06-26 | The University Of Hong Kong | Cell-matrix microspheres, methods for preparation and applications |
US20070293428A1 (en) * | 2006-06-19 | 2007-12-20 | Zanella John M | Methods of treating joint pain in a subject by using an anti-angiogenic agent |
US20080004703A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic, Inc. | Method of treating a patient using a collagen material |
US20080004431A1 (en) * | 2006-06-30 | 2008-01-03 | Warsaw Orthopedic Inc | Method of manufacturing an injectable collagen material |
US8399619B2 (en) * | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
US8118779B2 (en) * | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
EP2076220A2 (en) * | 2006-07-25 | 2009-07-08 | Musculoskeletal Transplant Foundation | Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation |
US20080058954A1 (en) * | 2006-08-22 | 2008-03-06 | Hai Trieu | Methods of treating spinal injuries using injectable flowable compositions comprising organic materials |
US20080064626A1 (en) * | 2006-09-08 | 2008-03-13 | Zanella John M | Methods of treating tendonitis in a subject by using an anti-cytokine agent |
WO2008051864A2 (en) * | 2006-10-24 | 2008-05-02 | Neville Alleyne | Method of treating spinal internal disk derangement |
US8057458B2 (en) * | 2006-10-30 | 2011-11-15 | Warsaw Orthopedic, Inc. | Method for treating facet pain |
US8105382B2 (en) | 2006-12-07 | 2012-01-31 | Interventional Spine, Inc. | Intervertebral implant |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
EP2124777A4 (en) | 2007-02-21 | 2013-06-05 | Benvenue Medical Inc | Devices for treating the spine |
EP2124778B1 (en) | 2007-02-21 | 2019-09-25 | Benvenue Medical, Inc. | Devices for treating the spine |
US20080255664A1 (en) * | 2007-04-10 | 2008-10-16 | Mdesign International | Percutaneously deliverable orthopedic joint device |
US20080255501A1 (en) * | 2007-04-10 | 2008-10-16 | Michael Hogendijk | Percutaneous delivery and retrieval systems for shape-changing orthopedic joint devices |
AU2008240191B2 (en) | 2007-04-12 | 2013-09-19 | Zimmer, Inc. | Compositions and methods for tissue repair |
US8864801B2 (en) * | 2007-04-30 | 2014-10-21 | Warsaw Orthopedic, Inc. | Method of deformity correction in a spine using injectable materials |
US20080299172A1 (en) * | 2007-06-04 | 2008-12-04 | Stuart Young | Tissue repair implant |
US8900307B2 (en) | 2007-06-26 | 2014-12-02 | DePuy Synthes Products, LLC | Highly lordosed fusion cage |
US20090024174A1 (en) | 2007-07-17 | 2009-01-22 | Stark John G | Bone screws and particular applications to sacroiliac joint fusion |
WO2009046399A1 (en) * | 2007-10-05 | 2009-04-09 | Hynes Richard A | Spinal stabilization treatment methods for maintaining axial spine height and sagital plane spine balance |
EP2237748B1 (en) | 2008-01-17 | 2012-09-05 | Synthes GmbH | An expandable intervertebral implant |
US8740912B2 (en) | 2008-02-27 | 2014-06-03 | Ilion Medical Llc | Tools for performing less invasive orthopedic joint procedures |
US20100004700A1 (en) * | 2008-03-05 | 2010-01-07 | Neville Alleyne | Method of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres |
US8469961B2 (en) * | 2008-03-05 | 2013-06-25 | Neville Alleyne | Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints |
US20100010549A1 (en) * | 2008-03-05 | 2010-01-14 | Neville Alleyne | device and method of minimally invasive extracapsular ligamentous augmentation for canine stifle ligament injuries |
CA2720580A1 (en) | 2008-04-05 | 2009-10-08 | Synthes Usa, Llc | Expandable intervertebral implant |
US7976578B2 (en) * | 2008-06-04 | 2011-07-12 | James Marvel | Buffer for a human joint and method of arthroscopically inserting |
US8163022B2 (en) | 2008-10-14 | 2012-04-24 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
US8974502B2 (en) * | 2008-10-30 | 2015-03-10 | Warsaw Orthopedic, Inc. | Methods, systems, and devices for treating intervertebral discs including intradiscal fluid evacuation |
US8702677B2 (en) * | 2008-10-31 | 2014-04-22 | Warsaw Orthopedic, Inc. | Device and method for directional delivery of a drug depot |
US8535327B2 (en) | 2009-03-17 | 2013-09-17 | Benvenue Medical, Inc. | Delivery apparatus for use with implantable medical devices |
US9526620B2 (en) | 2009-03-30 | 2016-12-27 | DePuy Synthes Products, Inc. | Zero profile spinal fusion cage |
US9414864B2 (en) * | 2009-04-15 | 2016-08-16 | Warsaw Orthopedic, Inc. | Anterior spinal plate with preformed drug-eluting device affixed thereto |
US8715223B2 (en) * | 2009-07-22 | 2014-05-06 | Warsaw Orthopedic, Inc. | Device and method for delivery of a drug depot near the nerve |
JP2013504389A (en) | 2009-09-11 | 2013-02-07 | アーティキュリンクス, インコーポレイテッド | Disc-shaped orthopedic device |
US9132207B2 (en) | 2009-10-27 | 2015-09-15 | Spine Wave, Inc. | Radiopaque injectable nucleus hydrogel compositions |
US9393129B2 (en) | 2009-12-10 | 2016-07-19 | DePuy Synthes Products, Inc. | Bellows-like expandable interbody fusion cage |
US8657859B2 (en) | 2009-12-16 | 2014-02-25 | Advanced Veterinary Solutions | Implant for promoting stability of the canine stifle joint |
US8652153B2 (en) | 2010-01-11 | 2014-02-18 | Anulex Technologies, Inc. | Intervertebral disc annulus repair system and bone anchor delivery tool |
US9554909B2 (en) | 2012-07-20 | 2017-01-31 | Jcbd, Llc | Orthopedic anchoring system and methods |
US9333090B2 (en) | 2010-01-13 | 2016-05-10 | Jcbd, Llc | Systems for and methods of fusing a sacroiliac joint |
US9788961B2 (en) | 2010-01-13 | 2017-10-17 | Jcbd, Llc | Sacroiliac joint implant system |
EP2523633B1 (en) | 2010-01-13 | 2016-12-21 | Jcbd, Llc | Sacroiliac joint fixation fusion system |
US9421109B2 (en) | 2010-01-13 | 2016-08-23 | Jcbd, Llc | Systems and methods of fusing a sacroiliac joint |
US9381045B2 (en) | 2010-01-13 | 2016-07-05 | Jcbd, Llc | Sacroiliac joint implant and sacroiliac joint instrument for fusing a sacroiliac joint |
US9907560B2 (en) | 2010-06-24 | 2018-03-06 | DePuy Synthes Products, Inc. | Flexible vertebral body shavers |
US8979860B2 (en) | 2010-06-24 | 2015-03-17 | DePuy Synthes Products. LLC | Enhanced cage insertion device |
AU2011271465B2 (en) | 2010-06-29 | 2015-03-19 | Synthes Gmbh | Distractible intervertebral implant |
US9402732B2 (en) | 2010-10-11 | 2016-08-02 | DePuy Synthes Products, Inc. | Expandable interspinous process spacer implant |
US20120116515A1 (en) * | 2010-10-25 | 2012-05-10 | Semler Eric J | Demineralized cortical bone implants |
US9358122B2 (en) | 2011-01-07 | 2016-06-07 | K2M, Inc. | Interbody spacer |
WO2012178018A2 (en) | 2011-06-24 | 2012-12-27 | Benvenue Medical, Inc. | Devices and methods for treating bone tissue |
US20130018467A1 (en) * | 2011-07-15 | 2013-01-17 | Sean Suh | Systems and Methods For Vertebral Body and Disc Height Restoration |
US20130282121A1 (en) * | 2012-03-22 | 2013-10-24 | Ann Prewett | Spinal facet augmentation implant and method |
US10179014B1 (en) | 2012-06-01 | 2019-01-15 | Nuvasive, Inc. | Systems and methods for promoting sacroiliac joint fusion |
US9307968B2 (en) * | 2012-06-15 | 2016-04-12 | The University Of Hong Kong | Materials and methods for filling biological cavities and preventing leakage of injected therapeutic agents |
US10245306B2 (en) | 2012-11-16 | 2019-04-02 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
US9737294B2 (en) | 2013-01-28 | 2017-08-22 | Cartiva, Inc. | Method and system for orthopedic repair |
EP2948068A4 (en) | 2013-01-28 | 2016-09-28 | Cartiva Inc | Systems and methods for orthopedic repair |
US9522070B2 (en) | 2013-03-07 | 2016-12-20 | Interventional Spine, Inc. | Intervertebral implant |
US10085783B2 (en) | 2013-03-14 | 2018-10-02 | Izi Medical Products, Llc | Devices and methods for treating bone tissue |
US9717539B2 (en) | 2013-07-30 | 2017-08-01 | Jcbd, Llc | Implants, systems, and methods for fusing a sacroiliac joint |
US9510872B2 (en) | 2013-03-15 | 2016-12-06 | Jcbd, Llc | Spinal stabilization system |
US9119732B2 (en) | 2013-03-15 | 2015-09-01 | Orthocision, Inc. | Method and implant system for sacroiliac joint fixation and fusion |
US9826986B2 (en) | 2013-07-30 | 2017-11-28 | Jcbd, Llc | Systems for and methods of preparing a sacroiliac joint for fusion |
US10245087B2 (en) | 2013-03-15 | 2019-04-02 | Jcbd, Llc | Systems and methods for fusing a sacroiliac joint and anchoring an orthopedic appliance |
WO2015017593A1 (en) | 2013-07-30 | 2015-02-05 | Jcbd, Llc | Systems for and methods of fusing a sacroiliac joint |
US9539041B2 (en) | 2013-09-12 | 2017-01-10 | DePuy Synthes Products, Inc. | Minimally invasive biomaterial injection system |
US9801546B2 (en) | 2014-05-27 | 2017-10-31 | Jcbd, Llc | Systems for and methods of diagnosing and treating a sacroiliac joint disorder |
US10064896B2 (en) | 2014-07-17 | 2018-09-04 | Vivex Biomedical, Inc. | Spinal disc regenerative composition and method of manufacture and use |
US9764122B2 (en) | 2014-07-25 | 2017-09-19 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having an occluding member |
US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10179191B2 (en) | 2014-10-09 | 2019-01-15 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
US10136958B2 (en) | 2014-10-28 | 2018-11-27 | Amendia, Inc. | Tissue protector and method of use |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
ES2693579T3 (en) | 2015-01-16 | 2018-12-12 | Spineovations, Inc. | Method of treatment of the intervertebral disc |
US11426290B2 (en) | 2015-03-06 | 2022-08-30 | DePuy Synthes Products, Inc. | Expandable intervertebral implant, system, kit and method |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
USD802755S1 (en) | 2016-06-23 | 2017-11-14 | Warsaw Orthopedic, Inc. | Drug pellet cartridge |
EP3474783B1 (en) | 2016-06-28 | 2023-05-03 | Eit Emerging Implant Technologies GmbH | Expandable, angularly adjustable intervertebral cages |
US11596523B2 (en) | 2016-06-28 | 2023-03-07 | Eit Emerging Implant Technologies Gmbh | Expandable and angularly adjustable articulating intervertebral cages |
US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
US10888433B2 (en) | 2016-12-14 | 2021-01-12 | DePuy Synthes Products, Inc. | Intervertebral implant inserter and related methods |
US10645921B2 (en) | 2016-12-20 | 2020-05-12 | Vivex Biologics Group, Inc. | Viable disc regenerative composition and method of manufacture and use |
US10398563B2 (en) | 2017-05-08 | 2019-09-03 | Medos International Sarl | Expandable cage |
US11344424B2 (en) | 2017-06-14 | 2022-05-31 | Medos International Sarl | Expandable intervertebral implant and related methods |
US10940016B2 (en) | 2017-07-05 | 2021-03-09 | Medos International Sarl | Expandable intervertebral fusion cage |
US10603055B2 (en) | 2017-09-15 | 2020-03-31 | Jcbd, Llc | Systems for and methods of preparing and fusing a sacroiliac joint |
US11446156B2 (en) | 2018-10-25 | 2022-09-20 | Medos International Sarl | Expandable intervertebral implant, inserter instrument, and related methods |
US11426286B2 (en) | 2020-03-06 | 2022-08-30 | Eit Emerging Implant Technologies Gmbh | Expandable intervertebral implant |
US11850160B2 (en) | 2021-03-26 | 2023-12-26 | Medos International Sarl | Expandable lordotic intervertebral fusion cage |
US11752009B2 (en) | 2021-04-06 | 2023-09-12 | Medos International Sarl | Expandable intervertebral fusion cage |
Family Cites Families (249)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US788625A (en) * | 1903-05-04 | 1905-05-02 | George C Blackmore | Floor or ceiling plate for pipes. |
US3551560A (en) * | 1967-10-02 | 1970-12-29 | Heinrich F Thiele | Process of reconstructing tendons,cartilage,nerve sheaths,and products |
CA962806A (en) * | 1970-06-04 | 1975-02-18 | Ontario Research Foundation | Surgical prosthetic device |
US3875595A (en) * | 1974-04-15 | 1975-04-08 | Edward C Froning | Intervertebral disc prosthesis and instruments for locating same |
US4085466A (en) * | 1974-11-18 | 1978-04-25 | National Research Development Corporation | Prosthetic joint device |
US4280954A (en) * | 1975-07-15 | 1981-07-28 | Massachusetts Institute Of Technology | Crosslinked collagen-mucopolysaccharide composite materials |
US4060081A (en) * | 1975-07-15 | 1977-11-29 | Massachusetts Institute Of Technology | Multilayer membrane useful as synthetic skin |
US4185813A (en) | 1978-05-17 | 1980-01-29 | Spann Donald C | Surgical body positioner |
CA1146301A (en) * | 1980-06-13 | 1983-05-17 | J. David Kuntz | Intervertebral disc prosthesis |
US4378224A (en) * | 1980-09-19 | 1983-03-29 | Nimni Marcel E | Coating for bioprosthetic device and method of making same |
US4344193A (en) * | 1980-11-28 | 1982-08-17 | Kenny Charles H | Meniscus prosthesis |
US4400833A (en) * | 1981-06-10 | 1983-08-30 | Kurland Kenneth Z | Means and method of implanting bioprosthetics |
US4350629A (en) * | 1981-07-29 | 1982-09-21 | Massachusetts Institute Of Technology | Procedures for preparing composite materials from collagen and glycosaminoglycan |
US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
US4505266A (en) * | 1981-10-26 | 1985-03-19 | Massachusetts Institute Of Technology | Method of using a fibrous lattice |
US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
US4424208A (en) | 1982-01-11 | 1984-01-03 | Collagen Corporation | Collagen implant material and method for augmenting soft tissue |
US4582640A (en) | 1982-03-08 | 1986-04-15 | Collagen Corporation | Injectable cross-linked collagen implant material |
US4787900A (en) * | 1982-04-19 | 1988-11-29 | Massachusetts Institute Of Technology | Process for forming multilayer bioreplaceable blood vessel prosthesis |
US4544516A (en) * | 1982-07-28 | 1985-10-01 | Battelle Development Corporation | Collagen orientation |
US4661111A (en) * | 1982-08-04 | 1987-04-28 | La Jolla Cancer Research Foundation | Polypeptide |
US4589881A (en) * | 1982-08-04 | 1986-05-20 | La Jolla Cancer Research Foundation | Polypeptide |
US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
IL68218A (en) * | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
US4801299A (en) * | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
EP0152431A4 (en) * | 1983-07-25 | 1986-11-27 | John C Medlen | Collagen ligament and tendon regeneration material. |
US4448718A (en) * | 1983-09-13 | 1984-05-15 | Massachusetts Institute Of Technology | Method for the preparation of collagen-glycosaminoglycan composite materials |
GB2148901A (en) * | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
MX163953B (en) * | 1984-03-27 | 1992-07-03 | Univ New Jersey Med | PROCEDURE FOR PREPARING A BIODEGRADABLE COLLAGEN MATRIX |
US4879135A (en) * | 1984-07-23 | 1989-11-07 | University Of Medicine And Dentistry Of New Jersey | Drug bonded prosthesis and process for producing same |
US4642117A (en) | 1985-03-22 | 1987-02-10 | Collagen Corporation | Mechanically sheared collagen implant material and method |
US4627853A (en) * | 1985-05-29 | 1986-12-09 | American Hospital Supply Corporation | Method of producing prostheses for replacement of articular cartilage and prostheses so produced |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
DE3631469A1 (en) * | 1986-09-16 | 1988-03-17 | Merck Patent Gmbh | METAL ORGANIC COMPOUNDS |
US5258043A (en) * | 1987-07-20 | 1993-11-02 | Regen Corporation | Method for making a prosthetic intervertebral disc |
US5108438A (en) * | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
US5007934A (en) * | 1987-07-20 | 1991-04-16 | Regen Corporation | Prosthetic meniscus |
US4772287A (en) * | 1987-08-20 | 1988-09-20 | Cedar Surgical, Inc. | Prosthetic disc and method of implanting |
US4907260A (en) * | 1987-10-05 | 1990-03-06 | Ambassador College | Telephone line communications control system |
US4976733A (en) * | 1988-02-03 | 1990-12-11 | Biomedical Design, Inc. | Prevention of prosthesis calcification |
US5067962A (en) * | 1989-04-18 | 1991-11-26 | Baxter International Inc. | Bioprosthetic ligament |
US4946792A (en) * | 1989-08-18 | 1990-08-07 | Osteotech, Inc. | Process for debriding bone |
US5106949A (en) * | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
US5229497A (en) * | 1990-10-03 | 1993-07-20 | Teepak, Inc. | Process for recovering collagen |
US5137514A (en) | 1990-11-01 | 1992-08-11 | Accumed Systems, Inc. | Inflation syringe assembly for percutaneous transluminal angioplasty |
US5192326A (en) * | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
US5713960A (en) * | 1991-07-06 | 1998-02-03 | Christensen; James Marlow | Prosthesis with improved biocompatibility made with N-vinyl polymers |
DE4125400C2 (en) * | 1991-07-31 | 2000-08-17 | Edwin Klaus | Use of insoluble collagen for the treatment of degenerative, non-inflammatory joint processes |
US5507810A (en) * | 1991-10-07 | 1996-04-16 | Osteotech, Inc. | Processing of fibrous connective tissue |
US6277112B1 (en) | 1996-07-16 | 2001-08-21 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
US5658593A (en) * | 1992-01-16 | 1997-08-19 | Coletica | Injectable compositions containing collagen microcapsules |
US5391203A (en) * | 1992-04-13 | 1995-02-21 | Scott P. Bartlett | Method of draining and filling soft tissue implant |
US5478739A (en) | 1992-10-23 | 1995-12-26 | Advanced Tissue Sciences, Inc. | Three-dimensional stromal cell and tissue culture system |
US5397352A (en) | 1993-08-27 | 1995-03-14 | Burres; Steven | Method of recollagenation |
US7166121B2 (en) | 1994-01-26 | 2007-01-23 | Kyphon Inc. | Systems and methods using expandable bodies to push apart cortical bone surfaces |
ATE361028T1 (en) | 1994-01-26 | 2007-05-15 | Kyphon Inc | IMPROVED INFLATABLE DEVICE FOR USE IN SURGICAL METHODS OF FIXATION OF BONE |
US6726691B2 (en) | 1998-08-14 | 2004-04-27 | Kyphon Inc. | Methods for treating fractured and/or diseased bone |
US6716216B1 (en) * | 1998-08-14 | 2004-04-06 | Kyphon Inc. | Systems and methods for treating vertebral bodies |
US6248110B1 (en) | 1994-01-26 | 2001-06-19 | Kyphon, Inc. | Systems and methods for treating fractured or diseased bone using expandable bodies |
NZ279442A (en) | 1994-01-26 | 1998-02-26 | Mark A Reiley | Bone treatment device; inflatable balloon for insertion into a bone; balloon details |
US5888220A (en) | 1994-05-06 | 1999-03-30 | Advanced Bio Surfaces, Inc. | Articulating joint repair |
US6140452A (en) * | 1994-05-06 | 2000-10-31 | Advanced Bio Surfaces, Inc. | Biomaterial for in situ tissue repair |
US6248131B1 (en) | 1994-05-06 | 2001-06-19 | Advanced Bio Surfaces, Inc. | Articulating joint repair |
US5571189A (en) | 1994-05-20 | 1996-11-05 | Kuslich; Stephen D. | Expandable fabric implant for stabilizing the spinal motion segment |
US5906827A (en) | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
SE9402528D0 (en) | 1994-07-19 | 1994-07-19 | Astra Ab | Hard tissue stimulant with electricity |
US6392118B1 (en) | 1994-07-20 | 2002-05-21 | Neurotech S.A. | Mx-1 conditionally immortalized cells |
US5935849A (en) | 1994-07-20 | 1999-08-10 | Cytotherapeutics, Inc. | Methods and compositions of growth control for cells encapsulated within bioartificial organs |
EP0700671B1 (en) | 1994-09-08 | 2001-08-08 | Stryker Technologies Corporation | Hydrogel intervertebral disc nucleus |
DE69532856T2 (en) | 1994-10-17 | 2005-04-21 | Raymedica Inc | Spinal disc-GRAFT |
US5562736A (en) | 1994-10-17 | 1996-10-08 | Raymedica, Inc. | Method for surgical implantation of a prosthetic spinal disc nucleus |
EP0713707A1 (en) | 1994-11-23 | 1996-05-29 | Collagen Corporation | In situ crosslinkable, injectable collagen composition for tissue augmention |
US6080194A (en) * | 1995-02-10 | 2000-06-27 | The Hospital For Joint Disease Orthopaedic Institute | Multi-stage collagen-based template or implant for use in the repair of cartilage lesions |
US20050186673A1 (en) | 1995-02-22 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
US20020095218A1 (en) * | 1996-03-12 | 2002-07-18 | Carr Robert M. | Tissue repair fabric |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
CA2172917A1 (en) | 1995-06-07 | 1996-12-08 | Hugh R. Mcmullin | Moldable collagen compositions for hard tissue repair and augmentation |
US6046379A (en) | 1995-06-07 | 2000-04-04 | Stone; Kevin R. | Meniscal xenografts |
US6122549A (en) * | 1996-08-13 | 2000-09-19 | Oratec Interventions, Inc. | Apparatus for treating intervertebral discs with resistive energy |
US6007570A (en) * | 1996-08-13 | 1999-12-28 | Oratec Interventions, Inc. | Apparatus with functional element for performing function upon intervertebral discs |
US6048964A (en) | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
ATE330644T1 (en) | 1995-12-18 | 2006-07-15 | Angiotech Biomaterials Corp | CROSS-LINKED POLYMER MATERIALS AND METHODS FOR USE THEREOF |
US6322786B1 (en) * | 1996-02-15 | 2001-11-27 | Kansas University Medical Center Research Institute, Inc. | Method of producing bone-inducing agent |
US6352558B1 (en) * | 1996-02-22 | 2002-03-05 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damage joint |
US5788625A (en) * | 1996-04-05 | 1998-08-04 | Depuy Orthopaedics, Inc. | Method of making reconstructive SIS structure for cartilaginous elements in situ |
WO1997045147A1 (en) * | 1996-05-28 | 1997-12-04 | 1218122 Ontario Inc. | Resorbable implant biomaterial made of condensed calcium phosphate particles |
US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
US6126682A (en) * | 1996-08-13 | 2000-10-03 | Oratec Interventions, Inc. | Method for treating annular fissures in intervertebral discs |
EP1230902A1 (en) | 1996-11-15 | 2002-08-14 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
GB9704749D0 (en) * | 1997-03-07 | 1997-04-23 | Univ London | Tissue Implant |
US6022376A (en) * | 1997-06-06 | 2000-02-08 | Raymedica, Inc. | Percutaneous prosthetic spinal disc nucleus and method of manufacture |
FR2764514B1 (en) | 1997-06-13 | 1999-09-03 | Biopharmex Holding Sa | IMPLANT INJECTED IN SUBCUTANEOUS OR INTRADERMAL WITH CONTROLLED BIORESORBABILITY FOR REPAIR OR PLASTIC SURGERY AND AESTHETIC DERMATOLOGY |
GB9714580D0 (en) * | 1997-07-10 | 1997-09-17 | Wardlaw Douglas | Prosthetic intervertebral disc nucleus |
WO1999004720A1 (en) | 1997-07-11 | 1999-02-04 | Reprogenesis Inc. | Repair of intervertebral disks |
US6080579A (en) | 1997-11-26 | 2000-06-27 | Charlotte-Mecklenburg Hospital Authority | Method for producing human intervertebral disc cells |
US7045076B2 (en) | 1998-01-07 | 2006-05-16 | Sears Petroleum & Transport Corp. & Sears Ecological Applications Co., Llc | Deicing solution |
US6123731A (en) * | 1998-02-06 | 2000-09-26 | Osteotech, Inc. | Osteoimplant and method for its manufacture |
EP1056413A4 (en) * | 1998-02-27 | 2003-08-20 | Bioelastics Res Ltd | Injectable implants for tissue augmentation and restoration |
US6179872B1 (en) | 1998-03-17 | 2001-01-30 | Tissue Engineering | Biopolymer matt for use in tissue repair and reconstruction |
EP1098672A4 (en) | 1998-05-18 | 2004-03-17 | Vincent Bryan | Balloon jack |
US6224630B1 (en) * | 1998-05-29 | 2001-05-01 | Advanced Bio Surfaces, Inc. | Implantable tissue repair device |
WO2000007639A1 (en) | 1998-08-07 | 2000-02-17 | Tissue Engineering, Inc. | Bone precursor compositions |
US20010055594A1 (en) * | 1998-09-25 | 2001-12-27 | Kjell Olmarker | Use of certain drugs for treating nerve root injury |
SE9803710L (en) * | 1998-09-25 | 2000-03-26 | A & Science Invest Ab | Use of certain substances for the treatment of nerve root damage |
US6958149B2 (en) * | 1998-10-06 | 2005-10-25 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
US6025538A (en) * | 1998-11-20 | 2000-02-15 | Musculoskeletal Transplant Foundation | Compound bone structure fabricated from allograft tissue |
US20010006948A1 (en) * | 1998-11-25 | 2001-07-05 | James D. Kang | Gene transfer to intervertebral disc cells |
JP2002531181A (en) | 1998-12-01 | 2002-09-24 | クック・バイオテック・インコーポレーテッド | Polymorphic collagen biomaterial medical device |
US6361551B1 (en) | 1998-12-11 | 2002-03-26 | C. R. Bard, Inc. | Collagen hemostatic fibers |
US6146422A (en) * | 1999-01-25 | 2000-11-14 | Lawson; Kevin Jon | Prosthetic nucleus replacement for surgical reconstruction of intervertebral discs and treatment method |
US6264659B1 (en) | 1999-02-22 | 2001-07-24 | Anthony C. Ross | Method of treating an intervertebral disk |
US6419944B2 (en) * | 1999-02-24 | 2002-07-16 | Edward L. Tobinick | Cytokine antagonists for the treatment of localized disorders |
US6197061B1 (en) | 1999-03-01 | 2001-03-06 | Koichi Masuda | In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage |
US6662805B2 (en) | 1999-03-24 | 2003-12-16 | The Johns Hopkins University | Method for composite cell-based implants |
US6428576B1 (en) * | 1999-04-16 | 2002-08-06 | Endospine, Ltd. | System for repairing inter-vertebral discs |
US6419702B1 (en) | 1999-08-13 | 2002-07-16 | Bret A. Ferree | Treating degenerative disc disease through transplantation of the nucleus pulposis |
US6340369B1 (en) * | 1999-08-13 | 2002-01-22 | Bret A. Ferree | Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix |
US6969404B2 (en) | 1999-10-08 | 2005-11-29 | Ferree Bret A | Annulus fibrosis augmentation methods and apparatus |
SE9902155L (en) | 1999-06-09 | 2000-12-10 | Bjoern Rydevik | Serum antibodies |
FR2797179B1 (en) | 1999-08-03 | 2002-03-08 | Michel Gau | INTERVERTEBRAL NUCLEAR PROSTHESIS AND SURGICAL IMPLANTATION METHOD |
US6352557B1 (en) * | 1999-08-13 | 2002-03-05 | Bret A. Ferree | Treating degenerative disc disease through transplantion of extracellular nucleus pulposus matrix and autograft nucleus pulposus cells |
US6344058B1 (en) * | 1999-08-13 | 2002-02-05 | Bret A. Ferree | Treating degenerative disc disease through transplantation of allograft disc and vertebral endplates |
US6793677B2 (en) | 1999-08-13 | 2004-09-21 | Bret A. Ferree | Method of providing cells and other biologic materials for transplantation |
US6648918B2 (en) | 1999-08-13 | 2003-11-18 | Bret A. Ferree | Treating degenerative disc disease through the transplantation of dehydrated tissue |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US6425919B1 (en) | 1999-08-18 | 2002-07-30 | Intrinsic Orthopedics, Inc. | Devices and methods of vertebral disc augmentation |
EP1328221B1 (en) | 1999-08-18 | 2009-03-25 | Intrinsic Therapeutics, Inc. | Devices for nucleus pulposus augmentation and retention |
US6936072B2 (en) | 1999-08-18 | 2005-08-30 | Intrinsic Therapeutics, Inc. | Encapsulated intervertebral disc prosthesis and methods of manufacture |
US6783546B2 (en) * | 1999-09-13 | 2004-08-31 | Keraplast Technologies, Ltd. | Implantable prosthetic or tissue expanding device |
US6264695B1 (en) * | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
US6436119B1 (en) | 1999-09-30 | 2002-08-20 | Raymedica, Inc. | Adjustable surgical dilator |
US6878167B2 (en) | 2002-04-24 | 2005-04-12 | Bret A. Ferree | Methods and apparatus for placing intradiscal devices |
US6939329B1 (en) | 1999-10-08 | 2005-09-06 | Harvest Technologies Corporation | Apparatus for holding and operating one or more syringes |
WO2003011155A2 (en) | 1999-10-20 | 2003-02-13 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US6592625B2 (en) * | 1999-10-20 | 2003-07-15 | Anulex Technologies, Inc. | Spinal disc annulus reconstruction method and spinal disc annulus stent |
US6309169B1 (en) * | 1999-11-04 | 2001-10-30 | Roper Holdings, Inc. | Pump deployment system |
DE19959975A1 (en) | 1999-12-13 | 2001-07-26 | Efmt Entwicklungs Und Forschun | Cannula serving as a passage for a medical instrument or a substance comprises an end section with a shape memory which is activated when a given transition temperature is reached |
US6623963B1 (en) * | 1999-12-20 | 2003-09-23 | Verigen Ag | Cellular matrix |
US7014633B2 (en) | 2000-02-16 | 2006-03-21 | Trans1, Inc. | Methods of performing procedures in the spine |
US6558390B2 (en) | 2000-02-16 | 2003-05-06 | Axiamed, Inc. | Methods and apparatus for performing therapeutic procedures in the spine |
CN100396249C (en) | 2000-04-07 | 2008-06-25 | 科丰公司 | Insertion devices and method of use |
US6723335B1 (en) | 2000-04-07 | 2004-04-20 | Jeffrey William Moehlenbruck | Methods and compositions for treating intervertebral disc degeneration |
US6324710B1 (en) | 2000-04-14 | 2001-12-04 | Arthur S. Hernandez | Prone support apparatus for spinal procedures |
WO2004043303A2 (en) | 2002-11-12 | 2004-05-27 | Regenex Ltd. | Expandable devices and methods for tissue expansion, regenerationand fixation |
US6749614B2 (en) | 2000-06-23 | 2004-06-15 | Vertelink Corporation | Formable orthopedic fixation system with cross linking |
CA2413353C (en) | 2000-06-29 | 2013-01-29 | Rita Kandel | Intervertebral disc |
US20020032155A1 (en) | 2000-06-30 | 2002-03-14 | Ferree Bret A. | Method of treating disc herniation and disc degeneration with concentrated growth and differentiation factors |
CA2415389C (en) * | 2000-07-14 | 2009-02-17 | Kyphon Inc. | Systems and methods for treating vertebral bodies |
DE60141653D1 (en) | 2000-07-21 | 2010-05-06 | Spineology Group Llc | A STRONG, POROUS NET BAG DEVICE AND ITS USE IN BONE SURGERY |
CN1192750C (en) | 2000-08-28 | 2005-03-16 | 迪斯科动力学公司 | Prosthesis of vertebral disc |
US20050154463A1 (en) | 2000-08-30 | 2005-07-14 | Trieu Hal H. | Spinal nucleus replacement implants and methods |
JP2004507318A (en) | 2000-08-30 | 2004-03-11 | エスディージーアイ・ホールディングス・インコーポレーテッド | Disc nucleus pulposus implant and method |
US20020026244A1 (en) | 2000-08-30 | 2002-02-28 | Trieu Hai H. | Intervertebral disc nucleus implants and methods |
EP1582166B1 (en) | 2000-09-07 | 2007-06-27 | Sherwood Services AG | Apparatus for the treatment of the intervertebral disc |
WO2002028417A1 (en) * | 2000-10-03 | 2002-04-11 | Collagenesis, Inc. | Methods for treating joints using viscoelastic collagen solutions |
US20020045942A1 (en) | 2000-10-16 | 2002-04-18 | Ham Michael J. | Procedure for repairing damaged discs |
WO2002034111A2 (en) | 2000-10-24 | 2002-05-02 | Cryolife, Inc. | In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics |
ES2238500T3 (en) | 2000-10-27 | 2005-09-01 | Sdgi Holdings, Inc. | RING REPAIR SYSTEM. |
US6613044B2 (en) | 2000-10-30 | 2003-09-02 | Allen Carl | Selective delivery of cryogenic energy to intervertebral disc tissue and related methods of intradiscal hypothermia therapy |
AU2002221370A1 (en) | 2000-11-15 | 2002-05-27 | Bio Syntech Canada Inc | Method for restoring a damaged or degenerated intervertebral disc |
US6712853B2 (en) | 2000-12-15 | 2004-03-30 | Spineology, Inc. | Annulus-reinforcing band |
US20020176893A1 (en) | 2001-02-02 | 2002-11-28 | Wironen John F. | Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue |
US7544196B2 (en) | 2001-02-20 | 2009-06-09 | Orthovita, Inc. | System and kit for delivery of restorative materials |
US20020115742A1 (en) | 2001-02-22 | 2002-08-22 | Trieu Hai H. | Bioactive nanocomposites and methods for their use |
US6776800B2 (en) * | 2001-02-28 | 2004-08-17 | Synthes (U.S.A.) | Implants formed with demineralized bone |
US20040083002A1 (en) | 2001-04-06 | 2004-04-29 | Belef William Martin | Methods for treating spinal discs |
US6632235B2 (en) | 2001-04-19 | 2003-10-14 | Synthes (U.S.A.) | Inflatable device and method for reducing fractures in bone and in treating the spine |
US20030008817A1 (en) | 2001-07-03 | 2003-01-09 | Tom Sander | Cross-link reversing agent |
AU2002329884A1 (en) | 2001-08-27 | 2003-03-10 | Regeneration Technologies, Inc. | Processed soft tissue for topical or internal application |
WO2003020327A2 (en) | 2001-09-06 | 2003-03-13 | Bone Sa | A cross-linked collagenous biomaterial |
US6736815B2 (en) | 2001-09-06 | 2004-05-18 | Core Medical, Inc. | Apparatus and methods for treating spinal discs |
AU2002336694A1 (en) | 2001-11-01 | 2003-05-12 | Lawrence M. Boyd | Devices and methods for the restoration of a spinal disc |
IL162273A0 (en) | 2001-12-05 | 2005-11-20 | Mathys Medizinaltechnik Ag | Intervertebral disk prosthesis or nucleus replacement prosthesis |
JP2005511207A (en) * | 2001-12-10 | 2005-04-28 | コルバー・ライフサイエンス・リミテッド | Intervertebral disc treatment methods, devices, and preparations |
WO2003066120A1 (en) | 2002-02-04 | 2003-08-14 | Ferree Bret A | Treating degenerative disc disease through transplantation of allograft disc |
ATE362354T1 (en) | 2002-04-04 | 2007-06-15 | Synthes Gmbh | DISC PROSTHESIS OR NUCLEUS REPLACEMENT PROSTHESIS |
US20030195630A1 (en) | 2002-04-10 | 2003-10-16 | Ferree Bret A. | Disc augmentation using materials that expand in situ |
DE10223332A1 (en) | 2002-05-25 | 2003-12-04 | Efmt Entwicklungs Und Forschun | Medical implant |
WO2003099230A2 (en) | 2002-05-28 | 2003-12-04 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
US7166133B2 (en) | 2002-06-13 | 2007-01-23 | Kensey Nash Corporation | Devices and methods for treating defects in the tissue of a living being |
ITVI20020140A1 (en) | 2002-06-26 | 2003-12-29 | Tecres Spa | DEVICE FOR THE MANUAL DOSING OF A MEDICAL FLUID, PARTICULARLY BONE CEMENT |
EP1545362A4 (en) | 2002-09-05 | 2006-05-03 | Arthrocare Corp | Methods and apparatus for treating intervertebral discs |
US20040054413A1 (en) | 2002-09-16 | 2004-03-18 | Howmedica Osteonics Corp. | Radiovisible hydrogel intervertebral disc nucleus |
US7744651B2 (en) | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
KR101095771B1 (en) | 2002-09-18 | 2011-12-21 | 워쏘우 오르쏘페딕 인코포레이티드 | Natural tissue devices and methods of implantation |
US20040054414A1 (en) * | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
US6932843B2 (en) | 2002-09-25 | 2005-08-23 | Medicinelodge, Inc. | Apparatus and method for the in-situ formation of a structural prosthesis |
US6827716B2 (en) | 2002-09-30 | 2004-12-07 | Depuy Spine, Inc. | Method of identifying and treating a pathologic region of an intervertebral disc |
US20040068234A1 (en) | 2002-10-03 | 2004-04-08 | Jeff Martin | Bone graft particle delivery apparatus and method |
US7135027B2 (en) | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
JP2006505331A (en) | 2002-11-05 | 2006-02-16 | スパインオロジー,インク. | Semi-artificial intervertebral disc replacement system |
AU2003230740B2 (en) | 2002-11-08 | 2008-10-09 | Warsaw Orthopedic, Inc. | Transpedicular intervertebral disk access methods and devices |
US20040101959A1 (en) | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
NL1022023C2 (en) | 2002-11-29 | 2004-06-03 | Dsm Nv | Artificial intervertebral disc. |
US20040186471A1 (en) | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
US20040192658A1 (en) | 2002-12-27 | 2004-09-30 | Angiotech International Ag | Compositions and methods of using collajolie |
CA2513680A1 (en) | 2003-01-17 | 2004-08-05 | Psinergi Corporation | Artificial nucleus pulposus and method of injecting same |
FR2850009B1 (en) | 2003-01-20 | 2005-12-23 | Spine Next Sa | TREATMENT ASSEMBLY FOR THE DEGENERATION OF AN INTERVERTEBRAL DISC |
US20070003525A1 (en) | 2003-01-31 | 2007-01-04 | Moehlenbruck Jeffrey W | Hydrogel compositions comprising nucleus pulposus tissue |
AU2004212942A1 (en) | 2003-02-14 | 2004-09-02 | Depuy Spine, Inc. | In-situ formed intervertebral fusion device |
US20040193274A1 (en) | 2003-03-28 | 2004-09-30 | Trieu Hai H. | Materials and methods for augmenting and/or repairing intervertebral discs |
US6969405B2 (en) | 2003-04-23 | 2005-11-29 | Loubert Suddaby | Inflatable intervertebral disc replacement prosthesis |
US8273347B2 (en) | 2003-05-13 | 2012-09-25 | Depuy Spine, Inc. | Autologous treatment of degenerated disc with cells |
MXPA05012275A (en) | 2003-05-13 | 2006-02-10 | Depuy Spine Inc | A method of treating degenerative disc disease. |
US6958077B2 (en) | 2003-07-29 | 2005-10-25 | Loubert Suddaby | Inflatable nuclear prosthesis |
US20050100538A1 (en) | 2003-07-31 | 2005-05-12 | Attawia Mohamed | Intradiscal injection of anti-oxidants |
US8579908B2 (en) | 2003-09-26 | 2013-11-12 | DePuy Synthes Products, LLC. | Device for delivering viscous material |
TW200511970A (en) | 2003-09-29 | 2005-04-01 | Kwan-Ku Lin | A spine wrapping and filling apparatus |
WO2005034781A1 (en) | 2003-09-29 | 2005-04-21 | Promethean Surgical Devices Llc | Devices and methods for spine repair |
US20050071012A1 (en) | 2003-09-30 | 2005-03-31 | Hassan Serhan | Methods and devices to replace spinal disc nucleus pulposus |
US7879102B2 (en) | 2003-09-30 | 2011-02-01 | Depuy Acromed, Inc. | Method for treatment of defects in the intervertebral disc |
CA2481663A1 (en) | 2003-10-01 | 2005-04-01 | Biomet Deutschland Gmbh | Device for the mixing and discharge of liquid and pulverulent materials for medical use |
WO2005034800A2 (en) | 2003-10-03 | 2005-04-21 | Acker David E | Prosthetic spinal disc nucleus |
JP4050215B2 (en) | 2003-10-20 | 2008-02-20 | ペンタックス株式会社 | Paste bone filler injector |
JP2007527273A (en) | 2003-10-22 | 2007-09-27 | イントリンジック セラピューティックス インコーポレイテッド | Intervertebral disc stable barrier |
GB2407580B (en) | 2003-10-28 | 2009-02-25 | Univ Cambridge Tech | Biomaterial |
EP1682196A2 (en) | 2003-11-10 | 2006-07-26 | Angiotech International Ag | Medical implants and anti-scarring agents |
JP2005152501A (en) | 2003-11-28 | 2005-06-16 | Kyocera Corp | Artificial nucleus pulposus and manufacturing method thereof |
US20050125066A1 (en) | 2003-12-08 | 2005-06-09 | Innovative Spinal Technologies | Nucleus replacement securing device and method |
US7763077B2 (en) | 2003-12-24 | 2010-07-27 | Biomerix Corporation | Repair of spinal annular defects and annulo-nucleoplasty regeneration |
EP1698358A4 (en) | 2003-12-26 | 2007-12-26 | Cardio Inc | Transplantable biomaterial and method of preparing the same |
EP1729672A2 (en) | 2004-01-08 | 2006-12-13 | Spine Wave, Inc. | Apparatus and method for injecting fluent material at a distracted tissue site |
WO2005070439A1 (en) | 2004-01-09 | 2005-08-04 | Regeneration Technologies Inc. | Implant comprising a human muscle tissue matrix |
US7488322B2 (en) | 2004-02-11 | 2009-02-10 | Medtronic, Inc. | High speed surgical cutting instrument |
EP1753860B1 (en) | 2004-02-20 | 2012-04-11 | Isto Technologies Inc. | Intervertebral disc repair and methods therefor |
US20050187556A1 (en) | 2004-02-25 | 2005-08-25 | Synecor, Llc | Universal percutaneous spinal access system |
US8784421B2 (en) | 2004-03-03 | 2014-07-22 | Boston Scientific Scimed, Inc. | Apparatus and methods for removing vertebral bone and disc tissue |
US20050203537A1 (en) | 2004-03-09 | 2005-09-15 | Wiley Roy C. | Orthopaedic injection restrictor apparatus and method |
US8945223B2 (en) | 2004-03-12 | 2015-02-03 | Warsaw Orthopedic, Inc. | In-situ formable nucleus pulposus implant with water absorption and swelling capability |
US8029511B2 (en) | 2004-03-22 | 2011-10-04 | Disc Dynamics, Inc. | Multi-stage biomaterial injection system for spinal implants |
WO2005092248A1 (en) | 2004-03-26 | 2005-10-06 | Nuvasive Inc. | Porous implant for spinal disc nucleus replacement |
US20050222538A1 (en) | 2004-03-30 | 2005-10-06 | Sdgi Holdings, Inc. | Surgical system for delivery of viscous fluids |
WO2005096970A2 (en) | 2004-03-31 | 2005-10-20 | Advanced Biomaterial Systems, Inc. | Methods and devices for cavity creation in mammalian bone tissue |
US7282065B2 (en) | 2004-04-09 | 2007-10-16 | X-Spine Systems, Inc. | Disk augmentation system and method |
US7452351B2 (en) | 2004-04-16 | 2008-11-18 | Kyphon Sarl | Spinal diagnostic methods and apparatus |
WO2005102433A2 (en) | 2004-04-23 | 2005-11-03 | Leonard Edward Forrest | Device for treatment or evacuation of intervertebral disc |
EP1591133A1 (en) | 2004-04-30 | 2005-11-02 | Synthes | Biologically active implants |
EP1759719B1 (en) | 2004-05-07 | 2015-01-07 | Seikagaku Corporation | Nucleus pulposus filler |
WO2005113032A2 (en) | 2004-05-21 | 2005-12-01 | Synthes (U.S.A.) | Replacement of nucleus pulposus using a hydrogel |
FR2870718B1 (en) | 2004-05-25 | 2006-09-22 | Spine Next Sa | TREATMENT ASSEMBLY FOR THE DEGENERATION OF AN INTERVERTEBRAL DISC |
US20050277996A1 (en) | 2004-05-28 | 2005-12-15 | Podhajsky Ronald J | Method of reducing pressure in a nucleus pulposus |
US20050273093A1 (en) | 2004-06-04 | 2005-12-08 | Scimed Life Systems, Inc. | Method of treating herniated intervertebral discs using cooled ablation |
CA2560222A1 (en) | 2004-06-22 | 2006-01-05 | Jeffrey E. Yeung | Disc shunt for treating back pain |
US20060019869A1 (en) | 2004-07-23 | 2006-01-26 | Thomas Dimauro M | Intradiscal anti-inflammatory therapy involving autologous adiponectin |
JP4972288B2 (en) | 2004-08-30 | 2012-07-11 | 富士フイルム株式会社 | Image sensor |
US20060286144A1 (en) | 2005-06-17 | 2006-12-21 | Chunlin Yang | Reinforced collagen scaffold |
US7595062B2 (en) | 2005-07-28 | 2009-09-29 | Depuy Products, Inc. | Joint resurfacing orthopaedic implant and associated method |
-
2002
- 2002-09-18 US US10/245,955 patent/US20040054414A1/en not_active Abandoned
-
2003
- 2003-09-16 CA CA002499111A patent/CA2499111A1/en not_active Abandoned
- 2003-09-16 AU AU2003267269A patent/AU2003267269B2/en not_active Ceased
- 2003-09-16 WO PCT/US2003/029278 patent/WO2004026189A2/en active Application Filing
- 2003-11-07 US US10/704,167 patent/US20040228901A1/en not_active Abandoned
- 2003-11-10 AU AU2003285198A patent/AU2003285198B2/en not_active Ceased
- 2003-11-10 EP EP03779522A patent/EP1562652A1/en not_active Withdrawn
- 2003-11-10 CA CA002505169A patent/CA2505169A1/en not_active Abandoned
- 2003-11-10 WO PCT/US2003/035959 patent/WO2004045667A1/en active Application Filing
-
2005
- 2005-04-28 US US11/117,025 patent/US7713303B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004026189A2 (en) | 2004-04-01 |
AU2003267269B2 (en) | 2009-02-26 |
US20040228901A1 (en) | 2004-11-18 |
US7713303B2 (en) | 2010-05-11 |
WO2004045667A1 (en) | 2004-06-03 |
EP1562652A1 (en) | 2005-08-17 |
AU2003285198A1 (en) | 2004-06-15 |
WO2004026189A3 (en) | 2007-12-21 |
US20040054414A1 (en) | 2004-03-18 |
CA2499111A1 (en) | 2004-04-01 |
US20050197707A1 (en) | 2005-09-08 |
AU2003285198B2 (en) | 2009-04-23 |
AU2003267269A1 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003285198B2 (en) | Collagen-based materials and methods for treating synovial joints | |
US7744651B2 (en) | Compositions and methods for treating intervertebral discs with collagen-based materials | |
US7731981B2 (en) | Collagen-based materials and methods for treating synovial joints | |
EP1465558B1 (en) | Use of cross-linked collagen for intervertebral disc treatment | |
Buckwalter et al. | Instructional course lectures, The American academy of orthopaedic surgeons-Articular Cartilage. Part II: Degeneration and osteoarthrosis, repair, regeneration, and transplantation | |
US7067123B2 (en) | Glue for cartilage repair | |
US20030069639A1 (en) | Methods and compositions for repair or replacement of joints and soft tissues | |
US20050222687A1 (en) | Cartilage implant assembly and method for implantation | |
US20080274157A1 (en) | Cartilage implant plug with fibrin glue and method for implantation | |
Galois et al. | Cartilage repair: Surgical techniques and tissue engineering using polysaccharide‐and collagen‐based biomaterials | |
WO2008151119A2 (en) | Compositions and methods for use of scar tissue in repair of weight bearing surfaces | |
KR20050057442A (en) | Collagen-based materials and methods for augmenting intervertebral discs | |
Reichert et al. | Treatment of Large Osteochondral Defects with Spongiosaplasty and Collagen Type I Hydrogel-Based Autologous Chondrocyte Implantation | |
Gacasan et al. | Articular Cartilage Repair: Augmentation, Regeneration, Replacement, and Substitution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |